CRISPR Therapeutics AG (CRSP): Price and Financial Metrics
CRISPR Therapeutics AG (CRSP)
Today's Latest Price: $93.83 USD
Updated Aug 5 12:20pm
Add CRSP to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
CRSP Stock Summary
- CRSP's current price/earnings ratio is 338.96, which is higher than 98% of US stocks with positive earnings.
- The price/operating cash flow metric for CRISPR Therapeutics AG is higher than 97.36% of stocks in our set with a positive cash flow.
- As for revenue growth, note that CRSP's revenue has grown 21,738.75% over the past 12 months; that beats the revenue growth of 99.95% of US companies in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to CRISPR Therapeutics AG are SLGL, ZLAB, CLSD, MDWD, and LIFE.
- Visit CRSP's SEC page to see the company's official filings. To visit the company's web site, go to www.crisprtx.com.
CRSP Stock Price Chart Technical Analysis Charts
CRSP Price/Volume Stats
| Current price | $93.83 | 52-week high | $97.82 |
| Prev. close | $94.57 | 52-week low | $32.30 |
| Day low | $92.00 | Volume | 454,983 |
| Day high | $94.58 | Avg. volume | 1,041,224 |
| 50-day MA | $78.37 | Dividend yield | N/A |
| 200-day MA | $60.46 | Market Cap | 6.58B |
CRISPR Therapeutics AG (CRSP) Company Bio
CRISPR Therapeutics AG focuses on the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene-editing platform. The company is based in Basel, Switzerland.
Loading social stream, please wait...